Method for rapid in vivo assessment of intravenous irritation of

Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

128630, G01N 3315

Patent

active

052663019

ABSTRACT:
The present invention is a method for rapid in vivo assessment of intravenous irritation of pharmaceutical compositions. The assessment of the vascular irritability of new pharmaceutical agents, vehicles and their pharmaceutical compositions has traditionally been limited to histological characterization of postinfusion damage. These studies utilized about 15 conscious animals and required about two weeks to complete. The method of the present invention in contrast utilizes fewer animals and can be completed in as short as only about 2-4 hr. In addition the direct observation is contemporaneous with the infusion and utilized a central vein.

REFERENCES:
Morita et al. "Intravenous Irritation Test of DI-63 in Rabbits" PreClin. Rep. 13(1) 1987 (Abstract).
Nomura et al. "Intravenous Irritation Test of Naftidrofuryl LS-121 LS-121 in Retroauricular Veins of Rabbits" PreClin. Rep. 11(2) 1985 Abstract.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for rapid in vivo assessment of intravenous irritation of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for rapid in vivo assessment of intravenous irritation of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for rapid in vivo assessment of intravenous irritation of will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2093715

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.